Small pinpricks of blood are used to screen newborns for serious health conditions—but this genetic data can have legal uses too.

Stanford Medicine officials relied on a faulty algorithm to determine who should get vaccinated first, and it prioritized some high-ranking doctors over patient-facing medical residents.

Illumina just announced a machine that can crack genomes twice as fast as its current version—and drive the cost down to $200 a pop.

Organoids are helping scientists study the coronavirus

Deep brain stimulation could help curb drug and alcohol addiction

The social media giant, which has faced scrutiny over its privacy practices in the past, will allow people to find information about health screenings and flu shots

The experiment raises major safety concerns for gene-edited babies

The IBM-built Summit has found a list of promising drugs for Covid-19

Proof of a prior infection could come with more freedom

But it still won’t be widely available for at least a year

The technique rejuvenated six damaged lungs

A major data breach shows genetic information is vulnerable to attack

A brain implant helped restore his sight after a tragic car crash

FDA has authorized 23andMe to market a consumer test that reports only 3 out of more than 1,000 known mutations in BRCA genes

How working from home could reshape society

Tweaking a person’s DNA could restore hearing to those born without it, but not everyone thinks deafness needs to be ‘cured’

The first clinical trials are slated to begin in the U.S. and Europe while others are stalled.

Two life-altering treatments could soon be available, but questions remain about how accessible and affordable they’ll be.

Worries about the ability to understand the results of direct-to-consumer genetic tests will go the way of long-ago concerns about understanding pregnancy tests.

Several gene therapies aim to restore a protein necessary for transmitting sound signals from the ear to the brain.

Bayer AG said on Thursday it has donated 3 million tablets of the malaria drug Resochin to the U.S. government for potential use to treat COVID-19.

When and how to get tested, plus the latest on the testing shortages

Instead of cutting out chunks of the genome to disable malfunctioning genes, base editing makes a smaller, more precise swap.

Jennifer Doudna, co-inventor of CRISPR-Cas 9 gene editing, urged caution as sensational report emerges in China

Gene-edited immune cells could help wipe out deadly tumors.

The one-time gene editing fix is meant to halt debilitating pain crises for sickle cell patients, who formerly could only be cured with a risky stem cell transplant.

A pan-coronavirus vaccine could be “one vaccine to rule them all,” and so far it has shown strong results in mice, hamsters, monkeys, horses and even sharks.

The experiment raises major safety concerns for gene-edited babies

CAR-T therapies were heralded as one-time cures for some dire cases. Many patients, it turns out, relapse over time after a complete remission.

Some scientists are serious about resurrecting zeppelins for low-carbon travel

Facing a storage crisis, the U.S. is investing $48 million to turn DNA into living hard drives

After 25 years, scientists are starting to make progress against the devastating illness.

The Nobel laureate chats with ‘Future Human’ about what her gene-editing companies are up to.

Miniature versions of the organ that guides food to the stomach could help scientists treat a variety of medical ailments.

An experiment tests whether the gene-editing technology can stop the virus from replicating, which would ultimately wipe out the infection.

Rapid and at-home tests could give results in minutes rather than days

A major data breach shows genetic information is vulnerable to attack

Strand Therapeutics has figured out a way to turn the molecule on and off in certain tissues to more precisely treat tumors.

A government project plans to temporarily alter human genes, and shield people from deadly radiation exposure

The unproven gene therapy aims to lengthen a person’s telomeres

Here’s a key question for the Rev. Derrick DeWitt, director of the Maryland Baptist Aged Home in West Baltimore, a 100-year-old nursing facility that has had no coronavirus infections: What w…

Two life-altering treatments could soon be available, but questions remain about how accessible and affordable they’ll be.

Orchid is offering polygenic risk scores for schizophrenia, diabetes, even cancer.  But is the consumer test for couples and their future children ahead of the science?

Sickle cell disease results from a homozygous missense mutation in the β-globin gene that causes polymerization of hemoglobin S. Gene therapy for patients with this disorder is complicated by the c...

It took 13 years to build the first full set of genetic blueprints for the human race by sequencing the DNA inside our cells that governs everything from eye color to risk of debilitating disease.B…

The FDA has yet to approve any drugs for life extension. But biotech company Loyal is now a step closer to bringing one to market—for dogs.

A major data breach shows genetic information is vulnerable to attack

A team of scientists has infused CRISPR-edited immune cells into patients with advanced gastrointestinal cancers — in hopes the approach will actually shrink tumors and help patients live longer.

The transplant in an animal named Cronutt points toward a new strategy to treat the disease. But many questions remain.

Rapid DNA sequencing is helping doctors treat critically ill infants in days rather than weeks.

Implanted devices let people control computers and prosthetic limbs with their minds. But nobody knows how long they’ll last—and when they’ll need upgrades.

Researchers behind a controversial paper have admitted that their results may be wrong.